These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30354458)

  • 1. The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.
    Diamond MP; Eisenberg E; Huang H; Coutifaris C; Legro RS; Hansen KR; Steiner AZ; Cedars M; Barnhart K; Ziolek T; Thomas TR; Maurer K; Krawetz SA; Wild RA; Trussell JC; Santoro N; Zhang H;
    Clin Trials; 2019 Feb; 16(1):3-10. PubMed ID: 30354458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.
    Helfand BT; Mongiu AK; Roehrborn CG; Donnell RF; Bruskewitz R; Kaplan SA; Kusek JW; Coombs L; McVary KT;
    J Urol; 2009 Jun; 181(6):2674-9. PubMed ID: 19375101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.
    Neuman MD; Gaskins LJ; Ziolek T;
    Clin Trials; 2018 Feb; 15(1):107-111. PubMed ID: 28982261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional review board variability in minimal-risk multicenter urogynecology studies.
    Harvie HS; Lowenstein L; Omotosho TB; Sanses T; Molden S; Hardy J; Brubaker L;
    Female Pelvic Med Reconstr Surg; 2012; 18(2):89-92. PubMed ID: 22453318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on Diamond et al.: The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.
    Klitzman R
    Clin Trials; 2019 Feb; 16(1):11-13. PubMed ID: 30360650
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
    Mansbach J; Acholonu U; Clark S; Camargo CA
    Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization and streamlining of research oversight for pragmatic clinical trials.
    O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD
    Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site Variability in Regulatory Oversight for an International Study of Pediatric Sepsis.
    Michelson KN; Reubenson G; Weiss SL; Fitzgerald JC; Ackerman KK; Christie L; Bush JL; Nadkarni VM; Thomas NJ; Schreiner MS;
    Pediatr Crit Care Med; 2018 Apr; 19(4):e180-e188. PubMed ID: 29377867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the institutional review board approval process in a multicenter observational critical care study.
    Polito CC; Cribbs SK; Martin GS; O'Keeffe T; Herr D; Rice TW; Sevransky JE
    Crit Care Med; 2014 May; 42(5):1105-9. PubMed ID: 24368345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of shared institutional review board compared with multiple individual site institutional review board models in a multisite clinical trial.
    Martin SL; Allman PH; Dugoff L; Sibai B; Lynch S; Ferrara J; Aagaard K; Zornes C; Wilson JL; Gibson M; Adams M; Longo SA; Staples A; Saade G; Beche I; Carter EB; Owens MY; Simhan H; Frey HA; Khan S; Palatnik A; August P; Irby L; Lee T; Lee C; Schum P; Chan-Akeley R; Duhon C; Rincon M; Gibson K; Wiegand S; Eastham D; Oparil S; Szychowski JM; Tita A;
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100861. PubMed ID: 36669562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.
    Koyfman SA; Agre P; Carlisle R; Classen L; Cheatham C; Finley JP; Kuhrik N; Kuhrik M; Mangskau TK; O'Neill J; Reddy CP; Kodish E; McCabe MS
    J Natl Cancer Inst; 2013 Jul; 105(13):947-53. PubMed ID: 23821757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
    Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
    Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of multicenter studies by multiple institutional review boards: characteristics and outcomes for perinatal studies implemented by a multicenter network.
    Abramovici A; Salazar A; Edvalson T; Gallagher N; Dorman K; Tita A;
    Am J Obstet Gynecol; 2015 Jan; 212(1):110.e1-6. PubMed ID: 25088862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of institutional review board practice variation on observational health services research.
    Green LA; Lowery JC; Kowalski CP; Wyszewianski L
    Health Serv Res; 2006 Feb; 41(1):214-30. PubMed ID: 16430608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research ethics board approval for an international thromboprophylaxis trial.
    Lutz K; Wilton K; Zytaruk N; Julien L; Hall R; Harvey J; Skrobik Y; Vlahakis N; Meade L; Matte A; Meade M; Burns K; Albert M; Cash BB; Vallance S; Klinger J; Heels-Ansdell D; Cook D;
    J Crit Care; 2012 Jun; 27(3):225-31. PubMed ID: 22305662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of local review on informed consent documents from a multicenter clinical trials consortium.
    Burman W; Breese P; Weis S; Bock N; Bernardo J; Vernon A;
    Control Clin Trials; 2003 Jun; 24(3):245-55. PubMed ID: 12757991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in Institutional Board Review for a Multisite Assessment of Resident Professionalism.
    Linden JA; Schneider JI; Cotter A; Drexel S; Frosch E; Martin ND; Canavan C; Holtman M; Mitchell PM; Feldman JA
    J Empir Res Hum Res Ethics; 2019 Apr; 14(2):117-125. PubMed ID: 30866723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.